Envestnet Asset Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.75M | Buy |
21,730
+9,879
| +83% | +$1.71M | ﹤0.01% | 2392 |
|
|
2025
Q1 | $1.85M | Buy |
11,851
+1,274
| +12% | +$199K | ﹤0.01% | 2788 |
|
|
2024
Q4 | $1.46M | Sell |
10,577
-1,762
| -14% | -$243K | ﹤0.01% | 2898 |
|
|
2024
Q3 | $1.84M | Buy |
12,339
+1,692
| +16% | +$253K | ﹤0.01% | 2713 |
|
|
2024
Q2 | $1.45M | Buy |
10,647
+6,333
| +147% | +$864K | ﹤0.01% | 2784 |
|
|
2024
Q1 | $652K | Buy |
4,314
+527
| +14% | +$79.7K | ﹤0.01% | 3283 |
|
|
2023
Q4 | $477K | Sell |
3,787
-2,852
| -43% | -$359K | ﹤0.01% | 3354 |
|
|
2023
Q3 | $622K | Buy |
6,639
+1,757
| +36% | +$165K | ﹤0.01% | 3132 |
|
|
2023
Q2 | $436K | Buy |
4,882
+1,244
| +34% | +$111K | ﹤0.01% | 3288 |
|
|
2023
Q1 | $390K | Buy |
3,638
+135
| +4% | +$14.5K | ﹤0.01% | 3310 |
|
|
2022
Q4 | $428K | Buy |
3,503
+277
| +9% | +$33.8K | ﹤0.01% | 3184 |
|
|
2022
Q3 | $333K | Buy |
3,226
+105
| +3% | +$10.8K | ﹤0.01% | 3275 |
|
|
2022
Q2 | $290K | Buy |
3,121
+875
| +39% | +$81.3K | ﹤0.01% | 3376 |
|
|
2022
Q1 | $264K | Buy |
2,246
+282
| +14% | +$33.1K | ﹤0.01% | 3524 |
|
|
2021
Q4 | $264K | Sell |
1,964
-7,963
| -80% | -$1.07M | ﹤0.01% | 3486 |
|
|
2021
Q3 | $1.58M | Buy |
9,927
+193
| +2% | +$30.8K | ﹤0.01% | 2247 |
|
|
2021
Q2 | $1.28M | Buy |
9,734
+714
| +8% | +$94K | ﹤0.01% | 2360 |
|
|
2021
Q1 | $1.16M | Sell |
9,020
-6,200
| -41% | -$799K | ﹤0.01% | 2291 |
|
|
2020
Q4 | $2.54M | Sell |
15,220
-1,255
| -8% | -$209K | ﹤0.01% | 1625 |
|
|
2020
Q3 | $2.54M | Sell |
16,475
-6,066
| -27% | -$936K | ﹤0.01% | 1486 |
|
|
2020
Q2 | $3.33M | Buy |
+22,541
| New | +$3.33M | ﹤0.01% | 1322 |
|